The most common adverse events (AEs) of grade 3 or higher were hypertension (14% of patients), increased alanine aminotransferase level (ALT, 12%), increased aspartate aminotransferase level (AST, 10%), hyponatremia (6%), and lymphopenia (6%). This evidence concerns the gene GPT and Hyponatremia.